Beam Global Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Beam Global (BEEM) on March 2, 2021, reporting events occurring on that date. The company is incorporated in Nevada and its common stock and warrants trade on the NASDAQ Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and listing status rather than financial performance.
Material Changes
The material change reported is the Company's noncompliance with Nasdaq Listing Rule 5605(c)(2)(A). This noncompliance stems from the death of Robert C. Schweitzer, a member of the Board of Directors and the Audit Committee, on February 21, 2021. His passing reduced the Audit Committee below the required minimum of three independent directors.
Outlook, Risks, and Management Commentary
- Regulatory Status: Nasdaq issued a letter on March 2, 2021, confirming the noncompliance.
- Cure Period: The Company is granted a cure period to regain compliance, which expires on August 20, 2021.
- Management Plan: The Company intends to appoint an additional independent director to the Audit Committee prior to the expiration of the cure period.
- Risk: Failure to appoint a new director by the deadline could result in delisting or failure to satisfy continued listing standards.
Investor Verification Checklist
- Verify the appointment of a new independent director to the Audit Committee before August 20, 2021.
- Monitor future 8-K filings for confirmation of compliance with Nasdaq Listing Rule 5605.
- Check for any additional governance changes resulting from the vacancy on the Board.